Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular CarcinomaJie Mei, Rong Guo, Yuhao Tang et al.|Frontiers in Oncology|2021Cited by 127
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinomaYihong Ling, Rong Guo, Jiewei Chen et al.|BMC Cancer|2020Cited by 67
Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort studyLianghe Lu, Yong‐Fa Zhang, Chong Zhong et al.|Liver International|2020Cited by 62
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinomaXiao-Ping Zhong, Rong Guo, Anna Kan et al.|Cell Death and Disease|2019Cited by 49
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 TherapyJie Mei, Rong Guo, Xuqi Sun et al.|Journal of Inflammation Research|2021Cited by 49